$31.46 Billion Women's Health Diagnostics Industry Outlook, 2030: Government Funding And Rising Healthcare Investments Fuel Expansion

(MENAFN- GlobeNewsWire - Nasdaq) Prenatal Testing Set to Surge as Maternal health Needs Increase and Diagnostic Technologies Advance

Dublin, Jan. 16, 2025 (GLOBE NEWSWIRE) -- The "Women's Health Diagnostics market Size, Share, & Trends Analysis by Application, End Use, and Region, 2025 to 2030" report has been added to ResearchAndMarkets.com's offering.

The global women's health diagnostics market size is expected to reach USD 31.46 billion by 2030. The market is expected to expand at a CAGR of 7.29% from 2025 to 2030. Rising adoption of point-of-care diagnostics and growing incidence of various chronic and lifestyle diseases are among the key factors stimulating the growth of the market. Besides this, introducing various awareness programs is also anticipated to work in favor the market during the forecast period.

Women's health diagnostics is witnessing high growth due to increased funding from various organizations. On the basis of end use, the market has been bifurcated into hospital & diagnostics centers and home. Hospitals and diagnostic centers accounted for a larger share in the market due to high number of visits to hospitals and more reliable detection.
The market in Asia-Pacific is likely to witness significant growth over the coming years. The growth of the market can be attributed to increasing investments in healthcare, growing focus of international device manufacturers on strengthening their distribution networks within the region, and epidemiological shift from infectious diseases to chronic diseases within regional boundaries.
Women's Health Diagnostics Market Report Highlights

• Increasing investments by governments and private bodies and rising disposable incomes are driving market growth
• Cancer accounted for the highest share in the market in 2024. The segment will register noteworthy growth during the forecast period owing to availability of early detection tests and government initiatives to tackle cancer
• Prenatal testing is estimated to be the fastest growing segment during the same period owing to rising prevalence of prenatal diseases, increasing maternal age, surging healthcare expenditure, and development of advanced diagnostic tests
• Geographically, North America dominated the market and accounted for the largest revenue share of 46.21% in 2024. It is anticipated to maintain its dominance through 2030, thanks to widening base of diagnostic and imaging centers, mounting cases of cancer, growing awareness about fertility testing, and spiraling adoption of point-of-care testing devices

Why should you buy this report?

• Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
• Competitive Landscape: Explore the market presence of key players worldwide.
• Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
• Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

• Market intelligence to enable effective decision-making
• Market estimates and forecasts from 2018 to 2030
• Growth opportunities and trend analyses
• Segment and regional revenue forecasts for market assessment
• Competition strategy and market share analysis
• Product innovation listing for you to stay ahead of the curve

Key Attributes

Report Attribute	Details
No. of Pages	150
Forecast Period	2024-2030
Estimated Market Value (USD) in 2024	$20.6 billion
Forecasted Market Value (USD) by 2030	$31.46 billion
Compound Annual Growth Rate	7.2%
Regions Covered	Global

Key Topics Covered
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Regional outlook
2.4. Competitive Insights
Chapter 3. Women's Health Diagnostics Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising Prevalence of Various Health Conditions in Women
3.2.1.2. Growing Women Health Awareness
3.2.1.3. Technological Advancements in Diagnostics Equipment
3.2.1.4. Aging Women Population
3.2.1.5. Developing Global Healthcare Infrastructure
3.2.2. Market Restraint Analysis
3.2.2.1. Lack of Access of Diagnostic Solutions
3.2.2.2. High Cost of Diagnostic Solutions
3.3. Women's Health Diagnostics Analysis Tools
3.3.1. Industry Analysis - Porter's
3.3.2. PESTEL Analysis

Chapter 4. Women's Health Diagnostics Market: Segment Analysis, by Application, 2018 - 2030 (USD Million)
4.1. Definition and Scope
4.2. Application Market Share Analysis, 2024 & 2030
4.3. Women's Health Diagnostics Market, by Application, 2018 to 2030
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.4.1. Cancer
4.4.2. Infectious diseases
4.4.3. Osteoporosis
4.4.4. Pregnancy & fertility
4.4.5. Prenatal

Chapter 5. Women's Health Diagnostics Market: Segment Analysis, by End Use, 2018 - 2030 (USD Million)
5.1. Definition and Scope
5.2. End Use Market Share Analysis, 2024 & 2030
5.3. Global Women's Health Diagnostics Market, by End Use, 2018 to 2030
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.4.1. Hospitals
5.4.2. Laboratory
5.4.3. Home care
5.4.4. Others

Chapter 6. Women's Health Diagnostics Market: Regional Estimates & Trend Analysis
6.1. Regional Dashboard
6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030
6.3. North America
6.4. Europe
6.5. Asia Pacific
6.6. MEA

Chapter 7. Competitive Landscape
7.1. Market Participant Categorization
7.2. Recent Developments & Impact Analysis by Key Market Participants
7.3. Company Market Share Analysis, 2024
7.4. Key Company Profiles
7.4.1. F. Hoffmann-La Roche Ltd.
7.4.2. Hologic, Inc.
7.4.3. Quest Diagnostics Incorporated
7.4.4. Abbott
7.4.5. BD
7.4.6. GE Healthcare
7.4.7. Koninklijke Philips N.V.
7.4.8. Aspira Women's Health
7.4.9. Thermo Fisher Scientific Inc.
7.4.10. Cardinal Health, Inc.

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• Women's Health Diagnostics Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN16012025004107003653ID1109097339